HomeTPST • NASDAQ
add
Tempest Therapeutics Inc
Previous close
$6.50
Day range
$6.32 - $6.93
Year range
$5.35 - $47.45
Market cap
25.22M USD
Avg Volume
71.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.94M | 37.15% |
Net income | -10.86M | -37.40% |
Net profit margin | — | — |
Earnings per share | -3.16 | 32.48% |
EBITDA | -10.87M | -37.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.51M | -33.46% |
Total assets | 32.16M | -27.52% |
Total liabilities | 21.03M | -11.43% |
Total equity | 11.13M | — |
Shares outstanding | 3.68M | — |
Price to book | 2.06 | — |
Return on assets | -74.24% | — |
Return on capital | -93.11% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.86M | -37.40% |
Cash from operations | -8.04M | -11.83% |
Cash from investing | — | — |
Cash from financing | -721.00K | -260.22% |
Net change in cash | -8.76M | -26.84% |
Free cash flow | -5.65M | -17.49% |
About
Founded
2011
Headquarters
Website
Employees
24
